Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Nautilus Biotechnology, a leader in single-molecule protein analysis, will join the Goldman Sachs 45th Annual Global Healthcare Conference. The event is set for June 10, 2024, at 8:40 a.m. ET. Nautilus' management will participate in a fireside chat, which will be available via live and archived webcast on their investor relations page.

Positive

• Participation in a prestigious event like the Goldman Sachs Healthcare Conference can enhance Nautilus' visibility and credibility in the biotech sector.
• The company's involvement in such events may attract potential investors and partnerships.
• The fireside chat provides an opportunity for Nautilus to communicate its achievements and future plans directly to investors and industry peers.

Negative

• The press release lacks detailed financial or clinical data, which might be important for making informed investment decisions.
• There is no mention of any new product launches, clinical trial results, or significant business developments, which could be seen as a lack of progress.
• Relying on participation in events alone without substantial updates may not significantly impact the stock price.

SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Goldman Sachs 45th Annual Healthcare Conference.

Nautilus’ management is scheduled to participate in a fireside chat on Monday, June 10, 2024, at 8:40 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

FAQ

What event is Nautilus Biotechnology participating in?

Nautilus Biotechnology is participating in the Goldman Sachs 45th Annual Global Healthcare Conference.

When is Nautilus Biotechnology's fireside chat scheduled?

The fireside chat is scheduled for June 10, 2024, at 8:40 a.m. Eastern Time.

Where can I access the webcast of Nautilus Biotechnology's presentation?

You can access the live and archived webcast on the 'Investors' section of the Nautilus Biotechnology website at www.nautilus.bio.

What is the significance of Nautilus Biotechnology participating in the Goldman Sachs Healthcare Conference?

Participation in the Goldman Sachs Healthcare Conference can enhance Nautilus Biotechnology's visibility and credibility in the biotech sector.